- Home
- Life Sciences
- Biotechnology
- Biological Therapy
- Biological Therapy Analysis & Statistics, January 2013 (p4)
Talk to Alison
(866) 682 9815
Search inside this page
Top countries
Publication dates
Publishers
- Global Data (119)
- Bioseeker (17)
- Global Markets Direct (80)
- France Innovation Scientifique et Transfert (4)
- MarketLine (11)
-
- Kuick Research (1)
- La Merie Publishing (8)
- Datamonitor (18)
- Axis Research Mind (15)
- Life Science Analytics (LSA) (13)
- GBI Research (11)
- Frost & Sullivan (10)
- Global Industry Analyst (10)
- Espicom Business Intelligence (6)
- BCC Research (4)
- Visiongain (4)
- CHI Insight Pharma Reports (3)
- Industry Experts (3)
- Infiniti Research Limited (3)
- RNCOS (3)
- TriMark Publications (3)
- Aruvian's R'search (2)
- BioInformatics (2)
- Currentpartnering (2)
- MarketsandMarkets (2)
- Pharmavision (2)
- SCRIP Insights (2)
- Barnes Reports (1)
- BioPharm Reports (1)
- Daedal Research (1)
- Ibisworld (1)
- PMR Ltd. (1)
- Transparency Market Research (1)
- Venture Planning Group (1)
All regions
data types
Free Market Research Guides to Download
Biological Therapy Analysis & Statistics, January 2013 (p4)
You might be interested in: stem cell, cell therapy, cytokine, more »
» Purchase Premium Reports
91-120 of about 300 reports
Pathfinder Cell Therapy, Inc. (PFND) - Medical Equipment - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a development stage company providing cell therapy technology for treatment of a wide range of diseases ...
- Industries : Biological Therapy
- Countries : United States
Stemgent, Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- January 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
Global Brachytherapy Devices Market 2012-2016
- $ 2 500
- Industry report
- January 2013
- by Infiniti Research Limited
TechNavio's analysts forecast the Global Brachytherapy Devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant ...
- Industries : Biological Therapy
- Countries : World
Cytokine PharmaSciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- January 2013
- by Global Data
Summary Cytokine PharmaSciences, Inc. (CPSI) is a privately held biopharmaceutical company, based in the US. It develops and manufactures drug delivery products. The company focuses on women's health, ...
- Industries : Biological Therapy
- Countries : United States
Cell Therapy Partnering Yearbook 2013
- $ 1 495
- Industry report
- January 2013
- by Currentpartnering
The Cell Therapy Partnering Yearbook 2013 report series provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...
- Industries : Biological Therapy
RNL BIO Co., Ltd. - Product Pipeline Review - 2012
- $ 1 500
- Company report
- December 2012
- by Global Markets Direct
RNL BIO Co., Ltd. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, "RNL BIO Co., Ltd. - Product Pipeline Review - 2012" provides data on the RNL BIO Co., Ltd.'s ...
- Industries : Biological Therapy
- Countries : World
Aplastic Anemia - Pipeline Review, H2 2012
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Aplastic Anemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Aplastic Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : World
Myeloproliferative Disorders - Pipeline Review, H2 2012
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Myeloproliferative Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Myeloproliferative Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...
- Industries : Biological Therapy
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2012', provides ...
- Industries : Biological Therapy
- Countries : World
Fanconi Anemia - Pipeline Review, H2 2012
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Fanconi Anemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Fanconi Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : World
Adenovirus Infections - Pipeline Review, H2 2012
- $ 2 000
- Company report
- December 2012
- by Global Markets Direct
Adenovirus Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Adenovirus Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Biological Therapy
- Countries : World
Global Tissue Engineering and Cell Therapy Market 2011-2015
- $ 2 000
- Industry report
- December 2012
- by Infiniti Research Limited
TechNavio's analysts forecast the Global Tissue Engineering and Cell Therapy market to grow at a CAGR of 18 percent over the period 2011-2015. One of the key factors contributing to this market growth ...
- Industries : Biological Therapy
- Countries : World
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
- $ 3 500
- Industry report
- December 2012
- by GBI Research
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity Summary GBI Research, the leading business ...
- Industries : Biological Therapy
- Countries : South Korea
Small-Molecule Targeted Cancer Therapies: World Market 2013-2023
- $ 2 492
- Industry report
- December 2012
- by Visiongain
Report Details Cancer treatment with small molecules - your guide to trends and revenue prospects What does the future hold for small targeted agents to treat cancers? Visiongain's updated report gives ...
- Industries : Biological Therapy
- Countries : World, United States
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)
- $ 700
- Industry report
- December 2012
- by Daedal Research
Today, stem cell banking is being witnessed as one of the most promising and emerging fields of life sciences. The stem cell banking market is further expected to witness increased significant growth as ...
- Industries : Biological Therapy
- Countries : India
Liver Cirrhosis - Pipeline Review, H2 2012
- $ 2 000
- Company report
- November 2012
- by Global Markets Direct
Liver Cirrhosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Liver Cirrhosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : World
Sezary Syndrome - Pipeline Review, H2 2012
- $ 2 000
- Company report
- November 2012
- by Global Markets Direct
Sezary Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sezary Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : World
Sjogren%s Syndrome - Pipeline Review, H2 2012
- $ 2 000
- Company report
- November 2012
- by Global Markets Direct
Sjogren's Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sjogren's Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Biological Therapy
- Countries : World, United States
The Market for Stem Cell Research Products: Current and Future Opportunities
- $ 3 200
- Industry report
- November 2012
- by BioInformatics
The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize ...
- Industries : Biological Therapy
Advanced Cell Technology, Inc. (Symbol:ACTC) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
- Countries : United States
ReNeuron Group plc (Symbol:RENE) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
Athersys, Inc. (Symbol:ATHX) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
- Countries : United States
Lifebank Corp. (Symbol:LBK) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
Cryo-Save Group N.V. (Symbol:CRYO) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biological Therapy
- Countries : Europe, South Africa, World, Africa, Netherlands
Fibrocell Science, Inc. (FCSC) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Fibrocell Science, Inc. (FCSI) is a autologous cellular therapeutic company. It undertakes the development of novel skin and tissue rejuvenation drugs for medical, aesthetic and scientific applications. ...
- Industries : Biological Therapy
Myelofibrosis - Pipeline Review, H2 2012
- $ 2 000
- Company report
- October 2012
- by Global Markets Direct
Myelofibrosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Myelofibrosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : United States, World
Plasma Cell Neoplasm - Pipeline Review, H2 2012
- $ 2 000
- Company report
- October 2012
- by Global Markets Direct
Plasma Cell Neoplasm - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Plasma Cell Neoplasm - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Biological Therapy
- Countries : World
Indolent Lymphoma - Pipeline Review, H2 2012
- $ 2 000
- Company report
- October 2012
- by Global Markets Direct
Indolent Lymphoma - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Indolent Lymphoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Biological Therapy
- Countries : World
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2012
- $ 2 000
- Company report
- October 2012
- by Global Markets Direct
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Waldenstrom Macroglobulinemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...
- Industries : Biological Therapy
- Countries : United States, World
Primary Systemic Amyloidosis - Pipeline Review, H2 2012
- $ 2 000
- Company report
- October 2012
- by Global Markets Direct
Primary Systemic Amyloidosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...
- Industries : Biological Therapy
- Countries : World
» Download Public Reports
About 1 100 reports
StemCells Inc. - Company Report for Year 2013
- Company report
- March 2013
- 30 pages
... Biotechnology company. Gfap and nestin are proteins that are co-expressed by certain key cells found in the human central nervous system. Each patent claims a cell culture of undifferentiated gfap+ nestin+ cells ...
Cell Therapy Market Analysis In The United Kingdom
February 2013» Read our Company Profiles
36 CompaniesGlaxoSmithKline P.L.C.
United StatesBioheart Inc.
United StatesCelgene Corp.
United StatesStemCells Inc.
United StatesGeron Corp.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
